Cross-protection between Venezuelan, Eastern, and Western equine encephalomyelitis (VEE, EEE, WEE) viruses was studied in the hamster by using challenge responses and neutralizing antibody titers as indexes of protection. Formalininactivated vaccines induced only homologous protection regardless of the sequence of vaccination or 
59%o protection against WEE and EEE challenges, respectively. Neither deleterious nor enhancing interaction occurred when attenuated VEE and inactivated WEE and EEE vaccines were employed in various sequences of immunization and all possible combinations. The most rapid and simple immunization scheme eliciting excellent homologous protection consisted of a single dose of combined attenuated VEE and inactivated WEE and EEE vaccines. Studies with attenuated strains of VEE, EEE, and WEE viruses showed that all elicited excellent homologous protection when administered singly. However, use of these live strains in many combinations and sequences resulted in a significant (P < 0.05 to <0.001) decrease in the protective efficacy of the WEE or EEE strains. These results are discussed in relation to serum neutralization test data obtained on sera drawn pre-and postchallenge.
For several years this Institute has directed a major research effort towards the development and evaluation of group A arbovirus vaccines for use in man, namely, those against Venezuelan, Eastern and Western equine encephalomyelitis virus (VEE, EEE, WEE) infections (1-3, 5, 11, 17) . Our ultimate goal was the development of an immunization scheme for the group A arboviruses which would elicit broad group protection while requiring as few vaccines and doses as possible. Such vaccination programs would be of greatest benefit to at-risk personnel such as laboratory workers, veterinarians, or troops stationed in endemic areas. To provide base-line data for future use in volunteer studies, vaccines were tested in hamsters singly, in combinations, and in various sequences to determine the degree of heterologous protection afforded. Reported here are the results of such studies.
MATERIALS AND METHODS
Challenge virus strains. California strain WEE virus (6), Cambridge strain EEE virus (6) (13) . These areexpressed as logio serum neutralization indexes (LNI).
RESULTS
Immunization with combined vaccines. In no instance did WEE or EEE vaccines given singly or combined, regardless of the number of doses, protect against challenge with VEE virus. Excellent homologous protection was induced by attenuated VEE vaccine when administered in any combination with the other vaccines. The degree of homologous and heterologous protection elicited by the VEE vaccine given singly has been relatively constant in separate experiments in which more than 500 hamsters have been challenged with these and other strains of WEE and EEE viruses (unpublished data). In contrast, inactivated VEE vaccine administered in a single 0.5-ml dose or in two 2.5-ml doses protected against homologous challenge only.
In preliminary studies on the practical aspects of human immunization with combined vaccines, Combined and sequential immunization with attenuated virus. In separate experiments, hamsters were inoculated via the ip route with attenuated strains of VEE, WEE, and EEE viruses by using various sequences of administration and all possible combinations. Sequential doses were administered 21 to 30 days apart, and all challenges were given ip 21 to 30 days after the last vaccine dose.
As shown in Table 4 , the three strains elicited excellent homologous protection when administered singly. VEE elicited the highest degree of heterologous protection and EEE elicited the lowest. Sequence of immunization had a significant effect (P < 0.001) in a few schema. For example, use of attenuated VEE with attenuated WEE virus resulted in a significant increase in protection against EEE challenge regardless of sequence. However, reversing the sequence of WEE and VEE virus vaccinations depressed homologous protection against WEE virus challenge.
In vaccination schedules employing attenuated WEE and EEE viruses, sequence had no significant effect on homologous protection but had a marked effect (P < 0.001) on protection against VEE challenge; i.e. WEE followed by EEE elicited 23%7, protection against VEE challenge, whereas the reverse order resulted in 68% protection.
Simultaneous administration of the three attenuated strains resulted in a significant (P < 0.001) decrease in the homologous protective efficacy of the WEE virus but had no appreciable effect on the homologous protection induced by EEE or VEE viruses. When WEE virus was given simultaneously with either VEE virus or EEE virus, there was a similar depression in its capacity to elicit homologous protection (P < 0.001). The homologous protection induced by EEE virus was depressed (P < 0.05) when administered with VEE virus but was unaffected by simultaneous administration with WEE virus. simultaneous vaccination; ( ) = unchanged; as with the monovalent vaccination groups, there were no significant increases in heterologous antibody after challenge.
As seen in Table 6 , the inactivated WEE and EEE vaccines given singly and in combined form elicited only homologous neutralizing antibody responses. Unlike the live vaccines, these killed preparations permitted limited replication of even the homologous challenge viruses, as indicated by viremia (unpublished data), with a resulting significant increase in antibody titers to the challenge viruses. Induction of heterologous antibody as a result of challenge was not noted. Combination of the attenuated VEE vaccine with these two killed vaccines resulted in an increase in prechallenge titers to EEE virus and, further, apparently prevented the increase in homologous antibody titer after challenge that was observed when the killed WEE and EEE vaccines were employed singly or in combined form.
Inactivated VEE vaccine whether given in a single (1 x) dose or two 5 x doses stimulated only homologous neutralizing antibody, the level of which was unaffected by homologous challenge. Sera from the few animals that survived heterologous challenge were not available for determination of antibody titers.
DISCUSSION
The inability of the inactivated WEE, EEE, and VEE vaccines to induce cross-protection was not totally unexpected for two reasons. First, the group A arboviruses are not as closely related serologically as are those in other groups (7) . Second, with inactivated viruses of animal tissue origin as immunizing agents, other investigators have also failed to demonstrate cross-protection (4, 18, 19 Although amply demonstrated by our data, the cross-protection induced by the attenuated VEE vaccine is an incompletely understood phenomenon. However, the absence of cross-protection in hamsters given two As has been the experience of others, heterologous challenge resulted in a significant rise in titer to the specific challenge virus alone (7, 20) . Although temporal antibody studies were not performed here, perhaps as suggested by Casals (7) , preexperienced animals may produce cross-reacting antibodies at an accelerated rate upon challenge. In this case, the temporal relationship between the invasiveness of the virus and the rate at which the animal synthesizes antibody may spell the difference between survival and death.
As a result of the studies described in this paper, our concept for the prophylaxis of group A arbovirus diseases has been changed to one of immunization with combined vaccines for specific geographical areas. Our major effort will be directed toward the development of vaccines against those (14) . To effect the geographical immunization program described, vaccines must therefore be developed for Mayaro and O'nyong nyong; studies are now in progress to achieve this end.
